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Identification of four lipocortin proteins and phosphorylation of 
lipocortin I by protein kinase C in cytosols of porcine thyroid cell 
cultures 
F Antomcelh, B, Omri*, M F Breton*, B. Rothhut+, F. Russo-Marie+, M Pavlowc-Hournac* and 
B. Haye 
Rewved 19 October I989 
Four proteins of the hpocortm family, hpocortm I (35 kDa), hpocortm II (36 kDa), lrpocortm V (32 kDa) and hpocortm VI (67-70 kDa), were 
ldentlfied m the cytosols of 2-day-old cultures of thyroid cells Only hpocortm I was phosphorylated m vitro m fully dlfferentlated, thyroid strmulat- 
mg hormane-treated cells (0 1 mu/ml) Protem kmase C was the only kmase actlvlty which phosphorylated hpocortm I Phosphorylatlon shifted 
its pI from 6 9 to 6 6 The m v&o phosphorylatlon of hpocorCm I was tmpalred m cultures exposed for 2 days to phorbol ester (IO-’ M), although 
It was present m both the cytosol and the particulate fmctton of these cells 
ttpocortm, Protem kmase C, Protem phospho~latlo~~ Thyroid, Cell culture 
1 u INTRODUCTION 2, MATERIALS AND METHODS 
A recent series of investigations suggests that lipo- 
cortins I and II are the best substrates for receptor 
(Epidermal growth factor and insulin) and oncogene- 
encoded tyrosme kmases [l-6] and for protein kmase C 
(PKC) [7-91. 
Thyroid cells were isolated from ptg giands by ~sconti~uous 
trypsuuzatlon and cultured as previously described [18] TSH 
(0 1 mu/ml) or phorbol ester (0 I PM) were added from the start of 
the culture perrod 
These protems are Ca”’ -pre&ipitabIe and bind to 
phospho~ipids [2]. They inhibit phospbolipase AZ 
actrvtty in vrtro and m viva [X%13] and this property 
decreases after therr pbosphorylation [14]. The exact 
mechanism of this inhibition remains unknown 1.151. 
At the end of the Z-day culture period, the cells were washed twice 
by centrifu~ng at 2oOxg for 7 mm, and the pellet was resuspended 
m 25 mM E&e-Hepes buffer, pH 7 2 Cells were kept frozen over- 
mght m dry tee before the protan kmase actlvrty was measured 
Thyroid cell cytosols and partrculate extracts were prepared as 
described m [17] 
We recently described the purification and character- 
ization of endonexm (32 kDa) and the presence of lipo- 
cortm I (35 kDa) in the pig thyroid gland [16]. We also 
demonstrated that the major endogenous ubstrates for 
thyroid PKC were soIubfe cytosohc proteins with 
molecular masses between 35 and 38 kDa f 171. 
2 2 Endogenous protem phosphorylatlon m vitro 
Cytosobc and particulate proteins were phosphorylated m vitro 
with protem kmases A and C as previously described [17] 
2 2 1 One-dlmenszonal gel eiectrophoresrs 
Abquots of mcubation mixtures were subjected to one-dtmenwonai 
The present study provtdes evidence that, among 
these proteins, Iipocortin I f35 kDa) 1s the best endo- 
genous substrate for the PKC in thyroid stimulating 
hormone (TSH)-treated Z-day-old cultures of thyroid 
cells, and that the m vitro phosphorylation of bpo- 
cortm I IS Impaired in cultures exposed to phorbol 
esters for 2 days 
SDS/polyacrylarnide gel electrophorests (5- 15% gel gradients) as 
described by Laemmh [Is] Iqocortms were identified by Western 
Blot analysis as described by Tow&n et al [2Oj and mod&ed by 
Rothhut et al [Zl] 
The radroactlve phos~hory~at~ protems were vtsualtzed by 
autora~ography 
2 2 2 Two-drmenszonal gel electrophoresrs 
Samples for two-dimennonal gel electrophoresls were prepared as 
were those for one-dlmenslonal electrophoresls, except that the con- 
centrations of prott!ms were doubled The phosphoryla~on reactlon 
was stopped according to @Farrell [22] m the presence of 9 5 M fmai 
concentration of urea The first clmmenslon separation was by iso- 
electric focusmg on an amphohne pH gradient from 4 to 8 8 The 
second Qmenslon was electrophoresis in 12 5% acrylarnide gel The 
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proteins were then transferred to nitro~llulose sheets and identified 
with specific antibodies and ~aminobenzidine staining. Phosphoryt 
ated proteins were visualized (after exposure to X-ray films) by auto- 
radiography. 
3. RESULTS 
3.1. one-dimensional gel electrophoresis (SDS-PAGE) 
3.1.1. Western blot analysis 
Lipocortin I (35 kDa) was present in the soluble and 
particulate fractions of TSI-I- and phorbol ester-treated 
cells (fig. la). The 33 kDa core protein was also observ- 
ed. This core protein was more abundant in the par- 
ticles from phorbol ester-treated cells than in those 
from TSH-treated cells. It was also present in PKC- 
activated cytosolic fractions from both phorbol ester. 
and TSH-treated cells. 
Lipocortin II (36 kDa) and its core protein were also 
present in soluble and particulate fractions, but their 
distribution was slightly different from that of lipo- 
cortin I (fig.Za}, The core protein was more abundant 
in particles, while the lipocortin II was predominant in 
cytosolic fractions from both phorbol ester and TSH- 
TSH CELLS 
Cytosol Particles 
treated cells. The core protein of lipo~ortin II was not 
enhanced in cytosolic fractions in the PKC-activated 
assay, as was the core protein of Iipocortin I. 
Both lipocortins were present in higher co~centra- 
tions in the cytosolic than in the particulate fractions, 
when evaluated by diaminobenzidine staining under the 
same experiments conditions. 
A 56 kDa protein was detected by the lipocortin I 
antibody and a 110 kDa protein band was detected with 
the lipocortin II antibody in the cytosolic fractions in 
some experiments. 
The above two Western blot nitrocellulose sheets 
were autoradiographed (figslb and 2b). A radioactive 
band with an apparent molecular mass of 35-36 kDa 
was present in the PKC-activated assay of the cytosolic 
fraction of TSII-treated cells. This radioactive band 
was not present in the other fractions of assays of TSH- 
treated cells or in any of the fractions and assays of 
phorbol ester-treated cells, 
However, the electrophoretic resolution on the one- 
dimensioonal gels was too low to discriminate between 
TPA CELLS 
1 cytasor Particles 
I C PK&FKCPL Ga I CPKAPKCPLGa I I C PKA~CPLCa C PKAPKCPL Ca 
WESTERN BLOT (s) 
AUTORADIOGRAPHY 
(4 
Fig.1. One-dimensional gel electrophoresis. (a) Western blot analysis with lipocortin I (35 kDa) antibody of the cposohc and particulate fractions 
from TSH-treated cells (left) and tetradecanoyl phorbol acetate (TPA)-treated cells (right). (b) Autoradiography of nitrocellulose sheets. Cytosolic 
and particulate fractions from TSH- and TPA-treated cells were phosphorylated under basal conditions (C), or in the presence of CAMP (%A), 
calcium + phosphatidyl serine + dioleine (PKC), phosphatidyl serine -t diolein (PL) or calcium alone (Ca) as described in section 2. 
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the two lipocortins (35 kDa and 36 kDa). We therefore 
performed a two-dimensional gel electrophoresis of 
cytosol extracts from TSH-treated cells, 
3.2. Two-dimensional gel e/ectrophoresis 
Four antibodies were used, recognizing lipocortin I 
(35 kDa), lipocortin II (36 kDa), lipocortin V (32 kDa) 
and lipocortin VI (6’7-70 kDa), The in vitro 
phosphorylations of endogenous proteins were carried 
out under basal (fig.31 or PKC-activated (fig.41 condi- 
tions. Analysis of Western blots and autoradiographs 
showed that lipocortins II, V, and VI were not phos- 
phorylated either under basal or PKC-activated con- 
ditions. Lipocortin I was strongly phosphorylated only 
in PKC-activated conditions (fig.&). It appeared in 
two forms, phospho~lated and unphospho~1~t~d 
(fig.4a,b). The phosphorylation apparently shifted its 
isoelectric point (ps) from 6.9 to 6.6. The p1 of lipo- 
cortin V (32 kDa) is the same in cultured cells and intact 
glands (p1 5.2) 1161. Thyroid lipocortin VI (67-70 kDa) 
has a pf of 5.9 and the pf of lipocortin II (36 kDa) is 
5.0, which is lower than in other tissues. 
Other unidentified endogenous PKC substrates with 
a relat,ive mass of 35 kDa were present in the cytosolic 
extracts of TSH-treated cells (fig.4b). Thyroid lipo- 
cortins were not substrates for the cAMPdependent 
protein kinase in any of the conditions tested. 
TSH CELLS 
CYbSOi Partities 
4. DISCUSSION 
We recently demonstrated the presence of lipo- 
cortinV in the cytosols of porcine thyroid ceils. This 
protein had an amino acid composition similar to that 
of monocyte lipocortin (32 kDa) and was recognized by 
antibodies raised against the monocyte protein. Lipo- 
cortin I (35 kDa) and its core protein (33 kDa) were also 
identified in thyroid cytosois using a recombinant 
lipocortin I antibody 1lSf. Here we report that cultured 
thyroid cells also contain these proteins plus two other 
molecules of this family, which were identified as 
lipocortin II and lipocortin VI by specific antibodies. 
Antibodies against lipocortin I and lipocortin II were 
nsed to show that these proteins were present in both 
the cytosol and the particulate fraction, but that their 
distribution between the two compartments was dif- 
ferent, as it is in some other cell systems [23]. Lipo- 
cortin I was found in both compartments, while 
lipocortin II was mainly present in the cytosol. 
Phosphoryla~on experiment showed that only the 
cytosolic lipocortins are phosphorylated~ and that PKC 
is the only kinase activity which phosphorylated them 
in our experimental conditions. It is interesting to note 
that particulate lipocortins were not phosphorylated, 
despite the presence of considerable PKC activity in 
this compartment [17]. This raises the question of 
TPA CELLS 
Cytcrsol Partictes 
C WAPKC PL Ca I I C PKA PKC PL Ca C PKA PKC PL Ca I 
WESTERN BL0-r (a) 
67.. 
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WESTERN BLOT (a) 
Fig.3. Tw~imens~o~ gel electrophoresis of cytosol from TSH- 
treated cehs ~~osp~ory~~ed un er basstt cond%ons. (a) Western Mot 
analysis with ~t~~~es against four lipocortins. The same Hut was 
exposed suecessivefy to the four antibodies. @) Autoradi~phy of 
nitroceilutose sheets. 
whether thF: particulate and cytosolic lipocortins are 
identical entities or distinct isoforms, with different 
characteristics. Three isoforms of cytosolic PKC (Em 8, 
y) are all able to phosphorylate Iipocortin I [24]. It is, 
however, not known whether particulate PKC is one of 
these isoforms. 
Of the four lipocortins present in thyroid glands, 
only lipoeortin I was ~~o~~~o~~a~~ in the cytoso~s of 
TSH-treated cells which are well-differentiated cells 
with a high PKC activity [ZS]. The pi of the phospho- 
rylated form of lipocortin I was different (66) from 
that of the non-phosphorylated molecules (6,9), This 
may indicate either that all molecules were not phos- 
phorylated under our experimental conditions (3 min) 
or that the lipocortin I molecule population is 
heterogeneous. The latter could explain the lack of 
phosphorylation of particulate lipocortins. 
Thyroid cells are dedifferentiated after treatment 
WESTERN BLOT (a) 
with phorbol ester and their PKC activity in the two 
compartments (cytosol and particulate) is completely 
desensitized in &d&y-old cultures [17], Lipocortin I is 
present in these cells, as revealed by Western blot 
analysis, but it was not phosphorylated, probably 
because of the Xack of enzyme, It is, however, possible 
that lipocortin molecules are modified in the presence 
of phorbol esters, preventing their phosphorylation, as 
has recently been suggested f&%j. 
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